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n the article by Bates ER, Babb JD, Casey DE, et al., “ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus
ocument on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert
onsensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid
tenting),” which appeared in the January 2/9, 2007 issue of the journal (J Am Coll Cardiol 2007;49:126–70), the following
orrection should be made:
On page 139, the fifth sentence under the heading “Lipid-Lowering Therapy,” 20 mg should be changed to 80 mg so that
he sentence reads, “The SPARCL (Stroke Prevention with Aggressive Reduction of Cholesterol Levels) trial studied
torvastatin 80 mg for secondary prevention of stroke in 4,731 patients without coronary artery disease and documented a
6% relative risk reduction for recurrent stroke (136,136a).”
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